Researchers have identified a pathway that triggers an immune response in cells with defective DNA repair. In particular, the ...

Platform data establish Modified DNA’s potential to overcome two of the barriers that have kept DNA from becoming a practical ...

A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

The study focused on rare DNA damage-repair (DDR) disorders, including Ataxia-Telangiectasia (A-T) and Bloom syndrome. These ...

A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people ...

Humans possess the genetic machinery that bears and bats use for hibernation, research has found. Is this the dawn of a new ...

Glioblastoma vaccine shows promise by activating immune response and improving survival in a phase 1 trial at Siteman Cancer Center.

Most of us never think about what happens to our photos, files, and data when we're gone—but Apple has a built-in solution ...

New vaccine approach: Researchers tested a DNA-based vaccine targeting multiple tumor-specific proteins in glioblastoma patients, showing strong immune activation. Survival gains seen: Two-thirds of ...

This article is written by a student writer from the Her Campus at UCLA chapter and does not reflect the views of Her Campus.

Researchers at the Technion have discovered how changes in genetic regulatory sequences can lead to alterations in the form and structure of animals—even when genetic regulatory systems are stable and ...